GlassScriptPhysician profile
Akhtar Amin
NPI 1063863439
$8,763.37
in general payments reported to CMS, 2019-2025
34 companies · $2,076 in 2025
The $2,076 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $890 · 2023: $401 · 2024: $5,396 · 2025: $2,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,062 · Travel and Lodging: $3,747 · Education: $65.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,061.57 |
| Travel and Lodging | $3,746.56 |
| Education | $65.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,865.84 | 2022-2025 | Corevalve Evolut R, Micra, Venaseal |
| Boston Scientific Corporation | $766.56 | 2025 | Versacross Connect Laac Access Solution |
| Abiomed | $729.61 | 2022-2025 | Impella |
| Chiesi USA, INC. | $267.65 | 2022-2023 | Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.01 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $237.99 | 2024-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $226.93 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $212.35 | 2022-2025 | Viewmate, Ensite Precision, Ensite |
| Pfizer INC. | $185.24 | 2024-2025 | |
| Inari Medical, INC. | $91.15 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $79.86 | 2023-2024 | Xarelto |
| Heartflow, INC. | $65.89 | 2025 | |
| Biotronik INC. | $59.69 | 2022 | |
| Zoll Circulation INC | $58.77 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Penumbra, INC. | $55.89 | 2024 | Indigo System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $52.71 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Life 2000 Ventilation System |
| La Jolla Pharmaceutical Company | $50.65 | 2024-2025 | Giapreza |
| Stryker Corporation | $48.88 | 2025 | Flowtriever |
| Philips North America LLC | $44.95 | 2023-2024 | (Ck4) Mcot |
| Astrazeneca Pharmaceuticals LP | $44.15 | 2024-2025 | Farxiga, Wainua |
| Kiniksa Pharmaceuticals International, Plc | $42.08 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $41.46 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Jazz Pharmaceuticals INC. | $38.02 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.12 | 2025 | |
| Merck Sharp & Dohme LLC | $34.04 | 2025 | Winrevair |
| Grifols USA, LLC | $28.81 | 2023-2024 | Prolastin-C Liquid |
| Thrombolex, INC. | $20.78 | 2024 | Bashir Endovascular Catheter |
| Lantheus Medical Imaging, INC. | $20.56 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.78 | 2025 | Onpattro |
| Amgen INC. | $17.08 | 2025 | Repatha |
| Verona Pharma, INC. | $15.89 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.82 | 2025 | Ofev |
| Electromed, INC. | $13.61 | 2024 | Smartvest |
| Novartis Pharmaceuticals Corporation | $13.55 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akhtar Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.